Menu
Annual · values202520242023202220212020201920182017
Operating Cash Flow-8.30 M USD-9.27 M USD-20.62 M USD-22.57 M USD-27.63 M USD-28.30 M USD-33.17 M USD-18.51 M USD-5.52 M USD
Depreciation & Amortization2.12 M USD2.11 M USD2.08 M USD421000 USD1.56 M USD2.37 M USD1.75 M USD624000 USD218000 USD
Stock-Based Compensation338000 USD54000 USD1.22 M USD447000 USD2.24 M USD4.08 M USD23.54 M USD14.73 M USD12.71 M USD
Capital Expenditures17000 USD67000 USD76000 USD17000 USD265000 USD67000 USD268000 USD582000 USD547000 USD
Cash Flow from Investing167000 USD-67000 USD-61000 USD21000 USD3.80 M USD15.93 M USD-16.03 M USD-582000 USD-547000 USD
Cash Flow from Financing5.34 M USD8.65 M USD8.39 M USD23.36 M USD14.96 M USD21.69 M USD-526000 USD75.17 M USD10.39 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-8.31 M USD-9.34 M USD-20.70 M USD-22.59 M USD-27.89 M USD-28.37 M USD-33.44 M USD-19.09 M USD-6.07 M USD

Catheter Precision, Inc. is a dynamic player in the medical technology sector, specializing in the development and commercialization of advanced catheters and related technologies. The company focuses on providing innovative solutions for electrophysiology, a branch of cardiology that examines and treats arrhythmias. Their products are designed to support physicians in diagnosing and treating heart rhythm disorders with precision and efficacy. Notable features of Catheter Precision’s offerings include cutting-edge technology that enhances the accuracy of cardiac interventions and improves patient outcomes. As part of the broader healthcare sector, the company contributes to advancing medical treatments and has a significant impact on the quality of care provided to patients with cardiac issues. By continually innovating and integrating state-of-the-art technologies, Catheter Precision plays a crucial role in the electrophysiology market, offering tools that empower healthcare professionals to deliver superior cardiac care.